Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer

Journal of Cellular Biochemistry

Volumn 97, Issue 6, 2006, Pages 1370-1378

  Mousa, Sarah ^a   Mousa, Shaker A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Angiogenesis; Dermal fibroblast; Endothelial cell; Fibroblast growth factor; Nicotine; Tumor growth

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NICOTINE; NICOTINIC RECEPTOR; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER GROWTH; CHICK; CHORIOALLANTOIS; COLON CANCER; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; GROWTH RATE AND GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SKIN FIBROBLAST;

CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASMS; NICOTINE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 33645669938     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20741     Document Type: Article

References (21)

1. Alberg AJ, Samet JM. 2003. Epidemiology of lung cancer. Chest 123(1 suppl):21S-49S.
2. Auerbach R, Kubai L, Knighton D, Folkman J. 1974. A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 41:391-394.
3. Casanova H, Ortiz C, Pelaez C, Vallejo A, Moreno ME, Acevedo M. 2002. Insecticide formulations based on nicotine oleate stabilized by sodium caseinate. J Agric Food Chem 50(22):6389-6394.
4. Dani JA, De Biasi M. 2001. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70(4):439-446.
5. De Flora S, D'Agostini F, Balansky R, Camoirano A, Bennicelli C, Bagnasco M, Cartiglias C, Tampa E, Longobardi MG, Lubet RA, Izzotti A. 2003. Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutation Res 523-524:237-252.
6. Edgren M, Lennernas B, Larsson A, Nilsson S. 1999. Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas. Anticancer Res 19(1B):869-873.
7. Folkman J. 1995. Angiogenesis in cancer, vascular, rheumatoid, and other diseases. Nat Med 1:27-31.
8. Folkman J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 suppl 16):15-18.
9. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. 1995. Definition of two angiogenic pathways by distinct alpha v integrins. Science 270(5241):1500-1502.
10. Grant DS, Lelkes PI, Fukuda K, Kleinman HK. 1991. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol 27A:327-336.
11. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. 2002. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110(4):527-536.
12. Ibukiyama C. 1996. Angiogenesis: Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions. Jpn Heart J 37(3):285-300.
13. Macklin KD, Maus AD, Pereira EF, Albuquerque EX, Conti-Fine BM. 1998. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther 287(1):435-439.
14. Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. 2003. Association between self-reported environmental tobacco smoke exposure and lung cancer: Modification by GSTP1 polymorphism. Int J Cancer 104(6):758-763.
15. Mousa SS, Mousa SA. 2005. Method for treating occlusive vascular diseases and wound healing. United States Patent Application 2005/0069518; March 31, 2005.
16. Mousa SS, Mousa S, Mousa SA. 2005. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52(1):59-65.
17. Ruegg C, Dormond O, Foletti A. 2002. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: Which side to target? Endothelium 9(3):151-160.
18. Ruegg C, Mariotti A. 2003. Vascular integrins: Pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 60(6):1135-1157.
19. Schuller HM. 1989. Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem Pharmacol 38(20):3439-3442.
20. Smith CJ, Livingston SD, Doolittle DJ. 1997. An international literature survey of "IARC Group I carcinogens" reported in mainstream cigarette smoke. Food Chem Toxicol 35(10-11):1107-1130.
21. Villablanca AC. 1998. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84(6):2089-2098.